Skip to main content

MEDIFAST INC

For the period ended Sep 30, 2026. Filed Oct 26, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 26, 2026

MED$13.37+4.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. – Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(U.S. dollars in thousands, except per share amounts)

Three months ended September 30, · Nine months ended September 30,
2026 · 2025 · 2026 · 2025
Revenue$72,048$89,409$224,476$310,692
Cost of sales22,00827,25069,28487,645
Gross profit50,04062,159155,192223,047
Selling, general, and administrative69,39866,240182,172229,457
Loss from operations(19,358)(4,081)(26,980)(6,410)
Other income
Interest income1,5081,4264,2334,096
Other income (expense)15(2)(21)3,057
1,5231,4244,2127,153
Income (loss) before provision for income taxes(17,835)(2,657)(22,768)743
Provision (benefit) for income taxes(324)(396)(35)1,296
Net loss$(17,511)$(2,261)$(22,733)$(553)
Loss per share - basic$(1.57)$(0.21)$(2.05)$(0.05)
Loss per share - diluted$(1.57)$(0.21)$(2.05)$(0.05)
Weighted average shares outstanding
Basic11,18110,99111,10810,977
Diluted11,18110,99111,10810,977

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

Three months ended September 30,Nine months ended September 30,
2026202520262025
Net loss$(17,511)$(2,261)$(22,733)$(553)
Other comprehensive income (loss), net of tax:
Unrealized net gains (losses) on investment securities(428)41(651)40
Comprehensive loss$(17,939)$(2,220)$(23,384)$(513)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.